CVS Health Corporation (LON:0HRS)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of GBP 70.18 billion. The enterprise value is 120.89 billion.

Market Cap	70.18B
Enterprise Value	120.89B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	Jul 22, 2025

Share Statistics

Current Share Class	1.27B
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.27B

Valuation Ratios

The trailing PE ratio is 21.22 and the forward PE ratio is 11.18.

PE Ratio	21.22
Forward PE	11.18
PS Ratio	0.25
PB Ratio	1.24
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.67, with an EV/FCF ratio of 34.65.

EV / Earnings	36.55
EV / Sales	0.43
EV / EBITDA	9.67
EV / EBIT	17.54
EV / FCF	34.65

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.07.

Current Ratio	0.80
Quick Ratio	0.58
Debt / Equity	1.07
Debt / EBITDA	4.88
Debt / FCF	17.31
Interest Coverage	3.05

Financial Efficiency

Return on equity (ROE) is 5.88% and return on invested capital (ROIC) is 3.66%.

Return on Equity (ROE)	5.88%
Return on Assets (ROA)	2.29%
Return on Invested Capital (ROIC)	3.66%
Return on Capital Employed (ROCE)	5.69%
Revenue Per Employee	1.08M
Profits Per Employee	12,744
Employee Count	300,000
Asset Turnover	1.50
Inventory Turnover	19.88

Taxes

In the past 12 months, CVS Health has paid 1.46 billion in taxes.

Income Tax	1.46B
Effective Tax Rate	30.89%

Stock Price Statistics

The stock price has increased by +35.04% in the last 52 weeks. The beta is 0.62, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+35.04%
50-Day Moving Average	67.04
200-Day Moving Average	62.41
Relative Strength Index (RSI)	69.46
Average Volume (20 Days)	5,961

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.44

Income Statement

In the last 12 months, CVS Health had revenue of GBP 280.52 billion and earned 3.31 billion in profits. Earnings per share was 2.62.

Revenue	280.52B
Gross Profit	37.32B
Operating Income	6.82B
Pretax Income	4.74B
Net Income	3.31B
EBITDA	10.20B
EBIT	6.82B
Earnings Per Share (EPS)	2.62

Balance Sheet

The company has 10.34 billion in cash and 60.38 billion in debt, giving a net cash position of -50.04 billion.

Cash & Cash Equivalents	10.34B
Total Debt	60.38B
Net Cash	-50.04B
Net Cash Per Share	n/a
Equity (Book Value)	56.60B
Book Value Per Share	44.58
Working Capital	-13.51B

Cash Flow

In the last 12 months, operating cash flow was 5.52 billion and capital expenditures -2.03 billion, giving a free cash flow of 3.49 billion.

Operating Cash Flow	5.52B
Capital Expenditures	-2.03B
Free Cash Flow	3.49B
FCF Per Share	n/a

Margins

Gross margin is 13.30%, with operating and profit margins of 2.43% and 1.18%.

Gross Margin	13.30%
Operating Margin	2.43%
Pretax Margin	1.69%
Profit Margin	1.18%
EBITDA Margin	3.64%
EBIT Margin	2.43%
FCF Margin	1.24%

Dividends & Yields

This stock pays an annual dividend of 2.04, which amounts to a dividend yield of 2.88%.

Dividend Per Share	2.04
Dividend Yield	2.88%
Dividend Growth (YoY)	-1.61%
Years of Dividend Growth	3
Payout Ratio	74.62%
Buyback Yield	1.02%
Shareholder Yield	3.90%
Earnings Yield	4.71%
FCF Yield	4.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.12 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	6